MedPath

Non-invasive Central Venous Pressure Estimation in Pediatric Patients

Not Applicable
Not yet recruiting
Conditions
Central Venous Pressure
Registration Number
NCT06885073
Lead Sponsor
Compremium AG
Brief Summary

Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria
  • Weight less than 2.5kg at the time of enrollment.
  • Bilateral external jugular veins not accessible due to vascular access or dressing.
  • Bilateral skin lesion contraindicating neck Ultrasound
  • Active bleeding
  • Clinically unstable, per clinical assessment by attending physician and/or surgeon

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Safety of external jugular venous occlusion pressure measured non-invasively with CPMX2 to estimate CVP in pediatric patients.Up to 4 days

Safety: Safety of the device shall be evaluated by systematically reporting DDs, ADEs and SADEs and by monitoring the frequency and incidence of these events. The practitioner will be asked to identify any new risks arising during the measurements using the investigational device.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath